MedsDelta is currently offering Erlonat from India, produced by Natco Pharma. It may come from other manufacturers around the world. Erlonat contains Erlotinib 150mg used in the treatment of non small cell lung cancer (NSCLC) that has spread (advanced) advanced pancreatic cancer. Call/WhatsApp: +91–9971646666, QQ: 3451266709 for buy Erlonat Erlotinib Tablet Natco from MedsDelta trusted medicine supplier and exporter of anti-cancer medicine at wholesale price. If you want to “Erlonat 150mg tablets online from India,” then MedsDelta is the best place to do this. Get Erlonat Erlotinib Tablet from MedsDelta delivering to countries Austria, Bahrain, Bangladesh, Belgium, Bhutan, Canada, Denmark, Finland, France, Germany, Hungry, Italy, Mexico, Netherlands, Norway, Oman, Philippines, Saudi Arabia, Sweden, Switzerland, UAE, UK, Ukraine, USA, Vietnam and many other. DingTalk: MedsDelta.
Erlonat Tablet Natco |
What is Erlotinib 150mg Tablet?
Erlotinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase that is used in the treatment of non-small cell lung cancer, pancreatic cancer and several other types of cancer.
What are the uses of Erlonat?
Erlonat 150 mg is used to treat:
Metastatic Non-Small Cell Lung Cancer
Pancreatic Cancer
What is the price of Erlotinib Tablet Natco?
To know more about the price of Erlonat Tablet manufactured by Natco from MedsDelta Trusted Medicine Supplier Contact with us. This product, along with many others, can be purchased from MedsDelta, one of the leading exporters of generic medicines.
Which US Brand is Equivalent To Erlonat 150 Mg (Erlotinib)?
Tarceva
For wholesale or retail inquiries, please contact us.
We mainly ship in Austria, Bahrain, Bangladesh, Belgium, Bhutan, Canada, Denmark, Finland, France, Germany, Hungry, Italy, Mexico, Netherlands, Norway, Oman, Philippines, Saudi Arabia, Sweden, Switzerland, UAE, UK, Ukraine, USA, Vietnam and many other countries.
Mail: MedsDelta@Gmail.Com,
Call/WhatsApp: +91–9971646666,
QQ: 3451266709,
WeChat or Skype: MedsDelta.
DingTalk: MedsDelta
No comments:
Post a Comment